57 results on '"Budäus, L."'
Search Results
2. 681 NERVE SPARING RADICAL PROSTATECTOMY IN PROPERLY SELECTED PATIENTS WITH PT3 PROSTATE CANCER DOES NOT UNDERMINE THE RATES OF POSITIVE SURGICAL MARGINS
3. 742 Only NeuroSAFE biopsy technique is suitable to assess positive surgical margins during nerve sparing radical prostatectomy compared to small biopsies taken from different locations of the neurovascular bundle.
4. MP-13.01 Radical Prostatectomy in Men with Continued Oral Aspirin Medication: Revisiting an Old Paradigm?
5. POD-03.01 Risk Assessment for Prostate Cancer Metastases by Using the Capra Score: Results from 3239 European Patients
6. 1045 PERIPROSTATIC FAT PADS HARBOR LYMPH NODES AND LYMPH NODE METASTASES: IMPACT ON PATHOLOGICAL WORK UP
7. 797 RISK ASSESSMENT FOR PROSTATE CANCER METASTASES BY USING THE CAPRA SCORE: RESULTS FROM 3209 EUROPEAN PATIENTS
8. 1081 OPEN RADICAL PROSTATECTOMY (ORP) PERFORMED BY LOW VOLUME SURGEONS PREDISPOSES TO HIGHER RATES OF VENOUS THROMBOSIS (VT) AND PULMONARY EMBOLISM (PE)
9. 670 CLINICAL STAGE AND THE BIOPSY GLEASON-SCORE SIGNIFICANTLY AFFECT THE RATE OF FAVORABLE HISTOPATHOLOGICAL STAGE AT RADICAL PROSTATECTOMY IN PATIENTS WITH VERY HIGH PREOPERATIVE PSA -VALUES (≥20 NG/ML)
10. 901 RADICAL PROSTATECTOMY IN MEN WITH CONTINUES ORAL ASPIRIN MEDICATION: REVISITING OLD PARADIGM?
11. C47 HEAD TO HEAD COMPARISON OF THE URINARY MARKER PCA3 AND PSA VELOCITY AS RISK FACTORS FOR PROSTATE CANCER PREDICTION IN PATIENTS UNDERGOING REPEAT PROSTATE BIOPSY
12. 979 PSA VELOCITY AND PCA3 SCORE AS RISK FACTORS FOR PROSTATE CANCER IN A REPEAT BIOPSY SETTING IMPROVES THE PREDICTIVE ACCURACY IN A MULTIVARIATE MODEL
13. 792 COMPARISON BETWEEN COMPLICATION RATES LENGTH OF STAY AND COSTS OF MINIMAL INVASIVE VS. OPEN RADICAL PROSTATECTOMY
14. 680 ELDERLY PATIENTS ARE AT A MORE ELEVATED RISK OF PT 3 PROSTATE CANCER: RESULTS OF A EUROPEAN SINGLE CENTER
15. 619 THE RISK OF GLEASON SUM UPGRADING REPRESENTS AN IMPORTANT CONSIDERATION IN PATIENTS ELIGIBLE FOR LOW DOSE BRACHYTHERAPY
16. 484 COMPARISON OF METHYLATION PATTERNS BETWEEN PRIMARY AND RECURRENT NON-MUSCLE INVASIVE BLADDER CANCER
17. A0551 - The conventional Briganti 2018 nomogram is superior to its side-specific adaptation in identifying candidates for extended pelvic lymph node dissection at radical prostatectomy.
18. A0427 - Size of lymph node metastases in prostate cancer patients undergoing radical prostatectomy: Implication for imaging and oncologic follow-up of 2705 lymph node positive patients.
19. A0309 - Bimodal imaging: Detection rate of clinically significant prostate cancer is higher in MRI lesions visible by transrectal ultrasound.
20. A0712 - PSA-density, DRE, and PI-RADS 5: Potential surrogates for omitting prostate biopsy?
21. A0525 - Surgical and oncological outcomes of salvage radical prostatectomy after focal therapies: A matched-pair analysis.
22. 520 - Clinical impact of "true whole-body" Ga-68-PSMA I&T PET/CT: Lesion frequency and added benefit in lower extremities.
23. A0484 - Nerve-Sparing Radical Prostatectomy (NSRP) using the NeuroSAFE technique is oncologically safe: Results after 20 years of experience.
24. A1122 - Complete biochemical response below 0.1 ng/ml predicts long-term therapy-free survival of patients treated with salvage lymph node dissection via PSMA-radioguided surgery.
25. A1113 - Integrating high-precision diagnostics in external-beam radiotherapy for personalized dose escalation of intraprostatic lesions.
26. A0657 - Impact of peritoneal bladder flap on the risk of lymphoceles after robotic radical prostatectomy: Results of a prospective controlled trial.
27. A0487 - Robot-assisted versus open radical prostatectomy: Outcomes of highly experienced surgeons for both approaches.
28. 1071 Diabetes and therapy of diabetes had no impact on BCR following radical prostatectomy (RP): Results from nearly 4200 contemporary patients.
29. 769 HOSPITAL VOLUME IS A DETERMINANT OF THE TYPE OF SURGERY, LENGTH OF STAY AND PERIOPERATIVE MORTALITY AT NEPHRECTOMY
30. 684 BIOCHEMICAL RECURRENCE AFTER RADICAL PROSTATECTOMY: A CASE OF MULTIPLICATIVE INTERACTION BETWEEN SURGICAL MARGIN STATUS AND PATHOLOGICAL STAGE
31. 288 ASSESSMENT OF MORTALITY FOR NON CANCER-RELATED MORTALITY IN PATIENTS WITH HISTOLOGICALLY PROVEN SMALL RENAL MASSES MANAGED NON-SURGICALLY
32. 971 THE EFFECT OF BODY MASS INDEX ON HISTOPATHOLOGICAL PARAMETERS; RESULTS OF A LARGE EUROPEAN CONTEMPORARY CONSECUTIVE OPEN RADICAL PROSTATECTOMY SERIES
33. Annual prostatectomy volume is related to rectal laceration rate after radical prostatectomy.
34. Blood Transfusions in Radical Prostatectomy: A Contemporary Population-based Analysis.
35. The European Network for the Study of Adrenal Tumors staging system is prognostically superior to the international union against cancer-staging system: a North American validation.
36. A0735 - Multiple suspicious PI-RADS lesions prior to mpMRI ultrasound fusion biopsy: Is it sufficient to target exclusively the index lesion?
37. A0511 - Cohort study of oligorecurrent prostate cancer patients: Oncological outcomes of patients treated with salvage lymph node dissection via PSMA radioguided surgery.
38. PT160 - Multivariable retrospective lesion based analyses of number of MRI ultrasound fusion targeted biopsy cores needed for prostate cancer detection in patients treated with radical prostatectomy.
39. 1225 - Prostate evaluation for clinically important disease: Sampling using image-guidance or not? (The PRECISION study, NCT02380027).
40. 851 - State-of-the-art automated extraction of detailed pathological data from narratively written electronic health records.
41. 677 - What is learning curve of robot-assisted radical prostatectomy (RARP) in a very highvolume open radical prostatectomy (RRP) center: Experience of a propensity matched-pair analysis of 10719 patients.
42. PT109 - Zonal distribution of prostate cancer foci in patients undergoing initial and multiple biopsy series: MRI fusion targeted results from 1,365 patients.
43. 404 - Accuracy of 68Ga-PSMA-PET for the detection of lymph node metastases before salvage lymphadenectomy – a real life scenario.
44. 1071 - Inverse stage migration patterns in North American patients undergoing local prostate cancer treatment: A contemporary population-based update in light of the 2012 USPSTF recommendations.
45. 572 Frozen section navigated radical prostatectomy significantly increase the frequency of nerve-sparing without compromising oncological outcome
46. 353 A new era of data extraction: Example of automated extraction PSA values from electronic health records.
47. 727 Inverse stage migration: Contemporary results of 140.253 North American prostate cancer patients treated with radical prostatectomy from 2004 to 2012.
48. 03 Bone scan index as a biomarker to predict outcome in mCRPC patients on abiraterone acetate (Zytiga™) – a multicenter study.
49. P065 Size and extension of lymph node metastases in prostate cancer patients: Implications for radiological imaging based on 6804 lymph nodes.
50. EO7 MRI use prior to prostate biopsy in a German tertiary care centre: A plea for standardization.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.